Format

Send to

Choose Destination
Am J Hematol. 2016 Feb;91(2):E3-5. doi: 10.1002/ajh.24240.

Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study.

Author information

1
The University of Texas MD Anderson Cancer Center, Houston, Texas.
2
Toronto Digestive Disease Associates, Inc, Vaughan, Ontario, Canada.
3
AMAG Pharmaceuticals, Inc, Waltham, Massachusetts.
PMID:
26572233
PMCID:
PMC4725221
DOI:
10.1002/ajh.24240
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center